• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Protective effect of influenza vaccination on outcomes in geriatric stroke patients: A nationwide matched cohort study

tetano

Editor, Senior Moderator
Atherosclerosis. 2019 Jan 26;282:85-90. doi: 10.1016/j.atherosclerosis.2019.01.008. [Epub ahead of print]
[h=1]Protective effect of influenza vaccination on outcomes in geriatric stroke patients: A nationwide matched cohort study.[/h] Lam F[SUP]1[/SUP], Chen TL[SUP]2[/SUP], Shih CC[SUP]3[/SUP], Lin CS[SUP]2[/SUP], Yeh CC[SUP]4[/SUP], Lee YJ[SUP]5[/SUP], Hu CJ[SUP]6[/SUP], Chiou HY[SUP]7[/SUP], Liao CC[SUP]8[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND AND AIMS:[/h] The effects of influenza vaccination (IV) on stroke outcomes are unclear. The purpose of this study is to evaluate the outcomes after stroke in elderly individuals who have received an IV.
[h=4]METHODS:[/h] We used Taiwan's National Health Insurance Research Database 2000-2009 claims data to conduct a nested stroke cohort study including 148,909 hospitalized stroke patients aged 66 years and older. Using a matching procedure by propensity score, we selected 25,248 stroke patients with IV and 25,248 stroke patients without IV for comparison. Logistic regression was used to calculate the odds ratios (ORs) and 95% CIs of post-stroke complications and in-hospital mortality associated with IV.
[h=4]RESULTS:[/h] Stroke patients with IV had significantly lower risks of post-stroke pneumonia (OR = 0.79; 95% CI, 0.74-0.83), septicemia (OR = 0.78; 95% CI, 0.70-0.86), urinary tract infection (OR = 0.87; 95% CI, 0.83-0.92), and 30-day in-hospital mortality (OR = 0.60; 95% CI, 0.54-0.67) compared with non-IV stroke patients. Vaccinated stroke patients also had shorter hospital stays (p < 0.0001) and less medical expenditures (p < 0.0001) during stroke admission than the control group. Lower rates of post-stroke adverse events in patients with IV were noted in both sexes of all age groups with various types of stroke.
[h=4]CONCLUSIONS:[/h] Stroke patients with IV showed fewer complications and lower mortality compared with non-IV patients. These findings suggest the urgent need to promote IV for this susceptible population of stroke patients.
Copyright ? 2019 Elsevier B.V. All rights reserved.


[h=4]KEYWORDS:[/h] Infectious diseases; Influenza vaccination; Mortality; Stroke

PMID: 30711633 DOI: 10.1016/j.atherosclerosis.2019.01.008
 
Back
Top Bottom